These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 27049060)

  • 21. A sphingosine-1-phosphate receptor type 1 agonist, ASP4058, suppresses intracranial aneurysm through promoting endothelial integrity and blocking macrophage transmigration.
    Yamamoto R; Aoki T; Koseki H; Fukuda M; Hirose J; Tsuji K; Takizawa K; Nakamura S; Miyata H; Hamakawa N; Kasuya H; Nozaki K; Hirayama Y; Aramori I; Narumiya S
    Br J Pharmacol; 2017 Jul; 174(13):2085-2101. PubMed ID: 28409823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sphingosine-1-Phosphate Lyase Inhibition Alters the S1P Gradient and Ameliorates Crohn's-Like Ileitis by Suppressing Thymocyte Maturation.
    Karuppuchamy T; Tyler CJ; Lundborg LR; Pérez-Jeldres T; Kimball AK; Clambey ET; Jedlicka P; Rivera-Nieves J
    Inflamm Bowel Dis; 2020 Jan; 26(2):216-228. PubMed ID: 31807751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacophore-based design of novel oxadiazoles as selective sphingosine-1-phosphate (S1P) receptor agonists with in vivo efficacy.
    Quattropani A; Sauer WH; Crosignani S; Dorbais J; Gerber P; Gonzalez J; Marin D; Muzerelle M; Beltran F; Nichols A; Georgi K; Schneider M; Vitte PA; Eligert V; Novo-Perez L; Hantson J; Nock S; Carboni S; de Souza AL; Arrighi JF; Boschert U; Bombrun A
    ChemMedChem; 2015 Apr; 10(4):688-714. PubMed ID: 25735812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting S1P in Inflammatory Bowel Disease: New Avenues for Modulating Intestinal Leukocyte Migration.
    Danese S; Furfaro F; Vetrano S
    J Crohns Colitis; 2018 Aug; 12(suppl_2):S678-S686. PubMed ID: 28961752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enterocyte dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin expression in inflammatory bowel disease.
    Zeng JQ; Xu CD; Zhou T; Wu J; Lin K; Liu W; Wang XQ
    World J Gastroenterol; 2015 Jan; 21(1):187-95. PubMed ID: 25574091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective effects of sphingosine-1-phosphate receptor agonist treatment after myocardial ischaemia-reperfusion.
    Hofmann U; Burkard N; Vogt C; Thoma A; Frantz S; Ertl G; Ritter O; Bonz A
    Cardiovasc Res; 2009 Jul; 83(2):285-93. PubMed ID: 19416991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation.
    Choi JW; Gardell SE; Herr DR; Rivera R; Lee CW; Noguchi K; Teo ST; Yung YC; Lu M; Kennedy G; Chun J
    Proc Natl Acad Sci U S A; 2011 Jan; 108(2):751-6. PubMed ID: 21177428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional antagonism of sphingosine-1-phosphate receptor 1 prevents cuprizone-induced demyelination.
    Kim S; Bielawski J; Yang H; Kong Y; Zhou B; Li J
    Glia; 2018 Mar; 66(3):654-669. PubMed ID: 29193293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic sphingosine 1-phosphate 1 receptor activation attenuates early-stage diabetic nephropathy independent of lymphocytes.
    Awad AS; Rouse MD; Khutsishvili K; Huang L; Bolton WK; Lynch KR; Okusa MD
    Kidney Int; 2011 May; 79(10):1090-8. PubMed ID: 21289599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolonging survival of corneal transplantation by selective sphingosine-1-phosphate receptor 1 agonist.
    Gao M; Liu Y; Xiao Y; Han G; Jia L; Wang L; Lei T; Huang Y
    PLoS One; 2014; 9(9):e105693. PubMed ID: 25216235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Sphingosine-1-Phosphate/Sphingosine-1-Phosphate Receptor 2 Axis in Intestinal Epithelial Cells Regulates Intestinal Barrier Function During Intestinal Epithelial Cells-CD4+T-Cell Interactions.
    Chen T; Lin R; Jin S; Chen R; Xue H; Ye H; Huang Z
    Cell Physiol Biochem; 2018; 48(3):1188-1200. PubMed ID: 30045015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of sphingosine 1-phosphate (S1P) receptor type 1 and type 4 in migratory response of mouse T cells toward S1P.
    Matsuyuki H; Maeda Y; Yano K; Sugahara K; Chiba K; Kohno T; Igarashi Y
    Cell Mol Immunol; 2006 Dec; 3(6):429-37. PubMed ID: 17257496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Type 1 sphingosine 1-phosphate G protein-coupled receptor signaling of lymphocyte functions requires sulfation of its extracellular amino-terminal tyrosines.
    Fieger CB; Huang MC; Van Brocklyn JR; Goetzl EJ
    FASEB J; 2005 Nov; 19(13):1926-8. PubMed ID: 16148028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sphingosine 1-phosphate receptor type 1 regulates egress of mature T cells from mouse bone marrow.
    Maeda Y; Seki N; Sato N; Sugahara K; Chiba K
    Int Immunol; 2010 Jun; 22(6):515-25. PubMed ID: 20497959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FTY720 ameliorates Th1-mediated colitis in mice by directly affecting the functional activity of CD4+CD25+ regulatory T cells.
    Daniel C; Sartory N; Zahn N; Geisslinger G; Radeke HH; Stein JM
    J Immunol; 2007 Feb; 178(4):2458-68. PubMed ID: 17277153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Full pharmacological efficacy of a novel S1P1 agonist that does not require S1P-like headgroup interactions.
    Gonzalez-Cabrera PJ; Jo E; Sanna MG; Brown S; Leaf N; Marsolais D; Schaeffer MT; Chapman J; Cameron M; Guerrero M; Roberts E; Rosen H
    Mol Pharmacol; 2008 Nov; 74(5):1308-18. PubMed ID: 18708635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The sphingosine-1-phosphate receptor-1 antagonist, W146, causes early and short-lasting peripheral blood lymphopenia in mice.
    Tarrasón G; Aulí M; Mustafa S; Dolgachev V; Domènech MT; Prats N; Domínguez M; López R; Aguilar N; Calbet M; Pont M; Milligan G; Kunkel SL; Godessart N
    Int Immunopharmacol; 2011 Nov; 11(11):1773-9. PubMed ID: 21798372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. S1P lyase in thymic perivascular spaces promotes egress of mature thymocytes via up-regulation of S1P receptor 1.
    Maeda Y; Yagi H; Takemoto K; Utsumi H; Fukunari A; Sugahara K; Masuko T; Chiba K
    Int Immunol; 2014 May; 26(5):245-55. PubMed ID: 24343820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. S1P analogues SEW2871, BAF312 and FTY720 affect human Th17 and Treg generation ex vivo.
    Zehra Okus F; Busra Azizoglu Z; Canatan H; Eken A
    Int Immunopharmacol; 2022 Jun; 107():108665. PubMed ID: 35255303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A selective sphingosine-1-phosphate receptor 1 agonist SEW-2871 aggravates gastric cancer by recruiting myeloid-derived suppressor cells.
    Zhou Y; Guo F
    J Biochem; 2018 Jan; 163(1):77-83. PubMed ID: 29036438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.